Jac-UP Tablet is a combination pharmaceutical formulation containing Glucosamine sulfate 750 mg, Diacerein 50 mg, and Methyl Sulfonyl Methane (MSM) 250 mg, designed to support joint health and alleviate symptoms associated with osteoarthritis and other degenerative joint disorders. Glucosamine acts as a key substrate for the biosynthesis of glycosaminoglycans and proteoglycans, essential components of cartilage matrix, thereby promoting cartilage repair and maintenance. Diacerein, an anthraquinone derivative, exhibits anti-inflammatory and chondroprotective properties by inhibiting interleukin-1 beta (IL-1β) activity, reducing cartilage degradation and joint inflammation. Methyl Sulfonyl Methane serves as a sulfur donor, contributing to the synthesis of connective tissue and exhibiting antioxidant effects that may reduce oxidative stress within joint structures. The synergistic action of these active ingredients helps improve joint mobility, reduce pain, and enhance overall joint function. Jac-UP Tablet is indicated for patients with mild to moderate osteoarthritis and other musculoskeletal disorders requiring symptomatic relief and cartilage support. It should be used under medical supervision, with caution in patients with known hypersensitivity to any components. Regular monitoring and adherence to prescribed dosage ensure optimal therapeutic outcomes and minimize adverse effects.